Clearside Biomedical Inc’s filing revealed that its Chief Medical Officer Chong Ngai Hang Victor acquired Company’s shares for reported $24910.0 on Jun 24 ’24. In the deal valued at $1.06 per share,23,500 shares were bought. As a result of this transaction, Chong Ngai Hang Victor now holds 63,500 shares worth roughly $76200.0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, YERXA BENJAMIN R bought 7,813 shares, generating $10,235 in total proceeds. Upon buying the shares at $1.31, the Director now owns 17,957 shares.
Before that, Gibney Anthony S bought 93,290 shares. Clearside Biomedical Inc shares valued at $121,277 were divested by the Director at a price of $1.30 per share. As a result of the transaction, Gibney Anthony S now holds 100,000 shares, worth roughly $0.12 million.
Chardan Capital Markets initiated its Clearside Biomedical Inc [CLSD] rating to a Buy in a research note published on August 21, 2024; the price target was $6. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who began to cover the stock in late June with a ‘”an Outperform”‘ rating. H.C. Wainwright started covering the stock on July 29, 2021. It rated CLSD as “a Buy”.
Price Performance Review of CLSD
On Monday, Clearside Biomedical Inc [NASDAQ:CLSD] saw its stock fall -8.40% to $1.20. Over the last five days, the stock has lost -8.40%. Clearside Biomedical Inc shares have risen nearly 2.56% since the year began. Nevertheless, the stocks have risen 43.63% over the past one year. While a 52-week high of $2.12 was reached on 03/12/24, a 52-week low of $0.65 was recorded on 09/05/24. SMA at 50 days reached $1.1150, while 200 days put it at $1.2703.
Levels Of Support And Resistance For CLSD Stock
The 24-hour chart illustrates a support level at 1.1067, which if violated will result in even more drops to 1.0133. On the upside, there is a resistance level at 1.3167. A further resistance level may holdings at 1.4333. The Relative Strength Index (RSI) on the 14-day chart is 53.36, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0746, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 39.13%. Stochastics %K at 74.64% indicates the stock is a holding.
How much short interest is there in Clearside Biomedical Inc?
A steep rise in short interest was recorded in Clearside Biomedical Inc stocks on 2024-08-30, growing by 0.13 million shares to a total of 0.34 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-31 was 0.21 million shares. There was a rise of 38.28%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on May 13, 2020 when ROTH Capital began covering the stock and recommended ‘”a Buy”‘ rating along with a $8 price target.
